HIPAA Act of 1996 :: Health, Health Information

The Health Insurance Portability and Accountability Act (HIPAA) of 1996 made it amerciable to gain access to personal medical information for any reasons other than health care delivery, operations, and reimbursements (Shi & Singh, 2008, p. 166). HIPAA legislation mandated strict controls on the transfer of personally recognisable health data between two entities, provisions for disclosure of defend information, and criminal penalties for violation (Clayton 2001). HIPAA also has privacy requirements that govern disclosure of diligent protected health information (PHI) placed in the medical record by physicians, nurses, and other health care providers (Buck, 2011). Always remember conversations about a patients health care or treatment is a violation of HIPAA. All PHI is included in the privacy requirements for example the patients past, familiarise or future physical or mental health or condition the provision of health care to the mortal, or the past, present, or future earni ngs for the provision of health care to the individual, and that identifies the individual or for which there is a reasonable basis to believe it can be used to identify the individual (Buck, 2011). Other identifiable health information would be the patients name, address, birth date and Social Security Number (Keomouangchanh, 2011). (Word count 197)There has been almost ethical issues surrounding the development and use of technology, that would consist of some advancements, such as when in vitro fertilization is applied in medical practice and leads to the occupation of spare embryos, the moral question is what to do with these embryos (Shi & Singh, 2008, p. 182). As for ethical dilemmas that comes into play with gene mapping of humans, genetic cloning, stem cell research, and others areas of growing interest to scientist (Shi & Singh, 2008, p. 182). living support technology raises serious ethical issues, especially in medical decisions regarding continuation or cessation of m echanical support, particularly when a patient exists in a permanent vegetative state (Shi & Singh, 2008, p. 182). Health care budgets are limited throughout this world, making it hard for advancements yet even harder to develop the advancements with restraints. Which brings us back to the social, ethical, and legal constraints, public and private insurers face the problem deciding whether or not to cover novel treatments 188. Similarly what was mentioned before the decisions about in the raw reproductive techniques such as intracytoplasmic sperm injection in vitro fertilization (ICSIIVF), new molecular genetics predictive tests for hereditary breast cancer, and the newer drugs such as sildenafil (Viagra) for sexual dysfunction (Giacomini, 2005).